Myriad Genetics, Inc. (NASDAQ:MYGN) Director Daniel K. Spiegelman Sells 8,638 Shares

Myriad genetics logo

Daniel K. Spiegelman, principal of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Rating), sold 8,638 shares in a deal on Friday, June 2. The stock sold at an average price of $23.01, for a total transaction of $198,760.38. As a result of the sale, the director now owns 40,493 shares of the company, valued at approximately … Read more